Recombinant PSMA (Rosopatamab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA, WB
Host: Humanized
Chimeric
unconjugated
Recombinant Antibody
-
- Target See all PSMA (Rosopatamab Biosimilar) products
- PSMA (Rosopatamab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Humanized
- Expression System
- Mammalian cells
-
Clonality
- Chimeric
-
Conjugate
- This PSMA (Rosopatamab Biosimilar) antibody is un-conjugated
- Application
- ELISA, Western Blotting (WB)
- Purpose
- Rosopatamab Biosimilar - Anti-FOLH1 mAb - Research Grade
- Characteristics
- Antibody Type: IgG1-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Purity
- > 85%
- Grade
- Research Grade
- Isotype
- IgG1 kappa
-
anti-PSMA (Rosopatamab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Mouse Chimeric unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer PH7.5
- Storage
- -80 °C
- Storage Comment
- store at -80°C
-
- Target
- PSMA (Rosopatamab Biosimilar)
- Abstract
- PSMA (Rosopatamab Biosimilar) Products
- Background
- Rosopatamab (HuJ591) is a humanized anti-PSMA IgG1 monoclonal antibody that can be used in cancer research, especially prostate cancer. Rosopatamab can be linked to the low-energy beta-emitting radioisotope lutetium-177 (177Lu) through the bifunctional chelator DOTA-NHS ester to obtain a radioimmunoconjugate that targets malignant prostate cells with high efficiency.
- CAS-No
- 2260767-49-3
-
You are here:
